Latest from The Tisch Cancer Institute

Fred R. Hirsch, MD, PhD, discusses the expansion of molecular testing in lung cancer.
William K. Oh, MD, discusses factors to consider when choosing a treatment for patients with metastatic hormone-sensitive prostate cancer. 
 
Hearn Jay Cho, MD, PhD, discusses investigational bispecific T-cell engager therapies in multiple myeloma.
Sundar Jagannath, MD, discusses the use and toxicity profile of selinexor in multiple myeloma treatment.
Ajai Chari, MD, discusses the use of selinexor in multiple myeloma treatment.
Samir Parekh, MBBS, discusses using genomics to treat patients with multiple myeloma.
We traveled to New York City, New York, for a State of the Science Summit™ on Multiple Myeloma, which featured insights from the faculty from the Mount Sinai Hospital.
Samir Parekh, MBBS, highlights ongoing research regarding personalized medicine for multiple myeloma.
Publication Bottom Border
Border Publication
x